{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T13:52:34.206651+00:00","published_at":"2026-10-16T13:52:34.206651+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1dvtegolzxbu2","event_type":"CFO_CHANGED","effective_at":"2026-03-23","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:christopher-sullivan","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:8b7d5600451594702af746bff56f68379ea2ed5af36acd77360b678ed5273c2c"],"summary":"Christopher Sullivan executive of Avalo Therapeutics, Inc., effective 2026-03-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:vn01zh1uumtmz","event_type":"CEO_CHANGED","effective_at":"2026-03-23","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:garry-neil-m-d","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:b19a82f8613f2ef8fe6f707422e1ac68ccb4f04142985440c6409224eb7b2625"],"summary":"Garry Neil, M.D. executive of Avalo Therapeutics, Inc., effective 2026-03-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:b69582izy5i6","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-23","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:jennifer-riley","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:a49aca0a54bdd430de20cb4cd9eac92cd2c64d14e8c359397c304e650220565d"],"summary":"Jennifer Riley executive of Avalo Therapeutics, Inc., effective 2026-03-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cbcpe0lspjqk","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-23","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:mittie-doyle-m-d-facr","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:52bf21d5233de11119d96fe0263f9b390c3c2bc83a62368294df8cae7199478c"],"summary":"Mittie Doyle, M.D., FACR executive of Avalo Therapeutics, Inc., effective 2026-03-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1sh1mzax0hmsu","event_type":"GC_CHANGED","effective_at":"2026-03-23","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:paul-varki","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:c4d1cd03c68dbfb8afbe7ae60982e7cc61bab20dd91c8f4716766f4ceeb2a38a"],"summary":"Paul Varki executive of Avalo Therapeutics, Inc., effective 2026-03-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:j5hncdt1btaz","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-23","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:taylor-boyd","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:887ce874f45629f9e203da039bfcb30d888c8bb3dca035734e64b98d73481a12"],"summary":"Taylor Boyd executive of Avalo Therapeutics, Inc., effective 2026-03-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:138hu36ip7g4y","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:kevin-lind","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Kevin Lind seat on Avalo Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1xwc46rujr543","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:michael-heffernan","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Michael Heffernan seat on Avalo Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:119et6h20r89j","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:rita-jain-m-d","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Rita Jain, MD seat on Avalo Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:4v57bw19s9etq","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:committee:avalo-therapeutics-inc:audit-chair-compensation","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Audit · Chair; Compensation committee of Avalo Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1waz07x17gjuch","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:kevin-lind","alpha:committee:avalo-therapeutics-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Kevin Lind member of Audit · Chair; Compensation, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1d6ee3c5m7dhm","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:aaron-kantoff","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Aaron Kantoff seat on Avalo Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:uzrzzb1chg85n","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:samantha-truex","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Samantha Truex seat on Avalo Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1yzyldg5prk2i","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:committee:avalo-therapeutics-inc:compensation-chair-nominating-and-governance","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Compensation · Chair; Nominating and Governance committee of Avalo Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wy4h91v5g7v3","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:aaron-kantoff","alpha:committee:avalo-therapeutics-inc:compensation-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Aaron Kantoff member of Compensation · Chair; Nominating and Governance, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:upxhv5rvc43j","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:committee:avalo-therapeutics-inc:compensation-nominating-and-governance-chair","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Compensation; Nominating and Governance · Chair committee of Avalo Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:522y1o1o4pozu","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:samantha-truex","alpha:committee:avalo-therapeutics-inc:compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Samantha Truex member of Compensation; Nominating and Governance · Chair, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1nrgcmb2lieiz","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:garry-neil-m-d","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Garry Neil, M.D. seat on Avalo Therapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:92mt7617h3mdg","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:52:34.206651+00:00","subject_ids":["alpha:person:gilla-kaplan-ph-d","alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285"],"caused_claim_ids":["alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66"],"summary":"Gilla Kaplan, Ph.D. seat on Avalo Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:5","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:aaron-kantoff","object_label":"Aaron Kantoff","object_source_name_forms":[],"value":"Aaron Kantoff: Director, Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:aaron-kantoff","name":"Aaron Kantoff"},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Avalo Therapeutics, Inc. DEF 14A 2026-04-10","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm","source_date":"2026-04-10","retrieved_at":"2026-04-24T23:14:02+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-10","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:6","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:garry-neil-m-d","object_label":"Garry Neil, M.D.","object_source_name_forms":[],"value":"Garry Neil, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:garry-neil-m-d","name":"Garry Neil, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Avalo Therapeutics, Inc. DEF 14A 2026-04-10","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm","source_date":"2026-04-10","retrieved_at":"2026-04-24T23:14:02+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-10","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:7","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gilla-kaplan-ph-d","object_label":"Gilla Kaplan, Ph.D.","object_source_name_forms":[],"value":"Gilla Kaplan, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gilla-kaplan-ph-d","name":"Gilla Kaplan, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Avalo Therapeutics, Inc. DEF 14A 2026-04-10","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm","source_date":"2026-04-10","retrieved_at":"2026-04-24T23:14:02+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-10","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:8","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kevin-lind","object_label":"Kevin Lind","object_source_name_forms":[],"value":"Kevin Lind: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kevin-lind","name":"Kevin Lind"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Avalo Therapeutics, Inc. DEF 14A 2026-04-10","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm","source_date":"2026-04-10","retrieved_at":"2026-04-24T23:14:02+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-10","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:9","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-heffernan","object_label":"Michael Heffernan","object_source_name_forms":[],"value":"Michael Heffernan: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-heffernan","name":"Michael Heffernan"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Avalo Therapeutics, Inc. DEF 14A 2026-04-10","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm","source_date":"2026-04-10","retrieved_at":"2026-04-24T23:14:02+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-10","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:10","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rita-jain-m-d","object_label":"Rita Jain, MD","object_source_name_forms":[],"value":"Rita Jain, MD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rita-jain-m-d","name":"Rita Jain, MD"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Avalo Therapeutics, Inc. DEF 14A 2026-04-10","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm","source_date":"2026-04-10","retrieved_at":"2026-04-24T23:14:02+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-10","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:11","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:samantha-truex","object_label":"Samantha Truex","object_source_name_forms":[],"value":"Samantha Truex: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:samantha-truex","name":"Samantha Truex"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Avalo Therapeutics, Inc. DEF 14A 2026-04-10","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm","source_date":"2026-04-10","retrieved_at":"2026-04-24T23:14:02+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-10","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:12","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christopher-sullivan","object_label":"Christopher Sullivan","object_source_name_forms":[],"value":"Christopher Sullivan: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christopher-sullivan","name":"Christopher Sullivan"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-23","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:8b7d5600451594702af746bff56f68379ea2ed5af36acd77360b678ed5273c2c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:53.728108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-23T00:00:00+00:00","effective_from":"2026-03-23","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:13","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:garry-neil-m-d","object_label":"Garry Neil, M.D.","object_source_name_forms":[],"value":"Garry Neil, M.D.: Chief Executive Officer, President, Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:garry-neil-m-d","name":"Garry Neil, M.D."},"title":"Chief Executive Officer, President, Chairman of the Board","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-23","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:b19a82f8613f2ef8fe6f707422e1ac68ccb4f04142985440c6409224eb7b2625","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:51.892515+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-23T00:00:00+00:00","effective_from":"2026-03-23","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:14","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jennifer-riley","object_label":"Jennifer Riley","object_source_name_forms":[],"value":"Jennifer Riley: Chief Strategy Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jennifer-riley","name":"Jennifer Riley"},"title":"Chief Strategy Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-23","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:a49aca0a54bdd430de20cb4cd9eac92cd2c64d14e8c359397c304e650220565d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:53.25733+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-23T00:00:00+00:00","effective_from":"2026-03-23","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:15","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mittie-doyle-m-d-facr","object_label":"Mittie Doyle, M.D., FACR","object_source_name_forms":[],"value":"Mittie Doyle, M.D., FACR: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mittie-doyle-m-d-facr","name":"Mittie Doyle, M.D., FACR"},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-23","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:52bf21d5233de11119d96fe0263f9b390c3c2bc83a62368294df8cae7199478c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:52.804884+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-23T00:00:00+00:00","effective_from":"2026-03-23","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:16","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:paul-varki","object_label":"Paul Varki","object_source_name_forms":[],"value":"Paul Varki: Chief Legal Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:paul-varki","name":"Paul Varki"},"title":"Chief Legal Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-23","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:c4d1cd03c68dbfb8afbe7ae60982e7cc61bab20dd91c8f4716766f4ceeb2a38a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:54.179777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-23T00:00:00+00:00","effective_from":"2026-03-23","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285:leadership_role:17","subject_id":"alpha:company:9e35a6cd-d8ed-4c3d-8d64-3c4567650285","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:taylor-boyd","object_label":"Taylor Boyd","object_source_name_forms":[],"value":"Taylor Boyd: Chief Business Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:taylor-boyd","name":"Taylor Boyd"},"title":"Chief Business Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-23","valid_to":null,"recorded_at":"2026-10-16T13:52:34.206651+00:00","sources":[{"id":"alpha:projection-evidence:document:887ce874f45629f9e203da039bfcb30d888c8bb3dca035734e64b98d73481a12","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:52.344416+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-23T00:00:00+00:00","effective_from":"2026-03-23","effective_until":null,"observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:5e728a89e502155d58640512228d8d8ee4b2396d2290e73ddcbdd05028ac9e66","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Avalo Therapeutics, Inc. DEF 14A 2026-04-10","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000022/avtx-20260408.htm","source_date":"2026-04-10","retrieved_at":"2026-04-24T23:14:02+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:8b7d5600451594702af746bff56f68379ea2ed5af36acd77360b678ed5273c2c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:53.728108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b19a82f8613f2ef8fe6f707422e1ac68ccb4f04142985440c6409224eb7b2625","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:51.892515+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a49aca0a54bdd430de20cb4cd9eac92cd2c64d14e8c359397c304e650220565d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:53.25733+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:52bf21d5233de11119d96fe0263f9b390c3c2bc83a62368294df8cae7199478c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:52.804884+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c4d1cd03c68dbfb8afbe7ae60982e7cc61bab20dd91c8f4716766f4ceeb2a38a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:54.179777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:887ce874f45629f9e203da039bfcb30d888c8bb3dca035734e64b98d73481a12","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AVTX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm","source_date":"2026-03-23T00:00:00+00:00","retrieved_at":"2026-05-15T23:10:52.344416+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.844,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.9,"cross_source_agreement":0.75,"temporal_completeness":0.684},"diagnostics":{"published_claims":26,"factual_claims":26,"claims_with_linked_evidence":26,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":19,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:52:34.206651+00:00","observed_at":"2026-10-16T13:52:34.206651+00:00","reviewed_at":"2026-10-16T13:52:34.206651+00:00","verified_at":"2026-10-16T13:52:34.206651+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/avalo-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/avalo-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}